We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,329 results
  1. Akimba Proliferative Diabetic Retinopathy Model: Understanding Molecular Mechanism and Drug Screening for the Progression of Diabetic Retinopathy

    As the prevalence of diabetes has reached epidemic proportions worldwide, diabetic retinopathy incidence is increasing rapidly. An advanced diabetic...
    Sai Bo Bo Tun, Veluchamy Amutha Barathi in Diabetic Retinopathy
    Protocol 2023
  2. TET2-mediated ECM1 hypomethylation promotes the neovascularization in active proliferative diabetic retinopathy

    Background

    Studies have shown that tet methylcytosine dioxygenase 2 (TET2) is highly expressed in diabetic retinopathy (DR), which reduces the DNA...

    Chunyang Cai, Chufeng Gu, ... Qinghua Qiu in Clinical Epigenetics
    Article Open access 03 January 2024
  3. Microglia in retinal angiogenesis and diabetic retinopathy

    Diabetic retinopathy has a high probability of causing visual impairment or blindness throughout the disease progression and is characterized by the...

    Aiyan Hu, Mirko H. H. Schmidt, Nora Heinig in Angiogenesis
    Article Open access 02 April 2024
  4. Bioinformatics Tools for Bulk Gene Expression Deconvolution in Diabetic Retinopathy

    Retinal neovascularization is one of the leading causes of vision loss and a hallmark of proliferative diabetic retinopathy (PDR). The immune system...
    Ru Qi Teh, Guei-Sheung Liu, Jiang-Hui Wang in Diabetic Retinopathy
    Protocol 2023
  5. Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes

    Objective

    Diabetic retinopathy (DR), especially proliferative diabetic retinopathy (PDR) is a common cause of blindness and visual impairment. Early...

    Huan Wang, Zhen Guo, Yu Xu in Journal of Translational Medicine
    Article Open access 13 May 2022
  6. Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities — preliminary data for PPPM validation

    Type 2 diabetes (T2DM) defined as the adult-onset type that is primarily not insulin-dependent, comprises over 95% of all diabetes mellitus (DM)...

    Martina Kropp, Eline De Clerck, ... Olga Golubnitschaja in EPMA Journal
    Article Open access 22 February 2023
  7. Enhancing deep learning pre-trained networks on diabetic retinopathy fundus photographs with SLIC-G

    Abstract

    Diabetic retinopathy disease contains lesions (e.g., exudates, hemorrhages, and microaneurysms) that are minute to the naked eye. Determining...

    Wei **ang Lim, Zhiyuan Chen in Medical & Biological Engineering & Computing
    Article 23 April 2024
  8. Oxygen-Induced Retinopathy in the Rat: An Animal Model to Study the Proliferative Retinal Vascular Pathology

    Diabetic retinopathy (DR) is one of the leading causes of vision loss worldwide. There are numerous animal models available for develo** new ocular...
    Yu-Fan Chuang, Fan-Li Lin in Diabetic Retinopathy
    Protocol 2023
  9. Diabetic retinopathy: emerging concepts of current and potential therapy

    Diabetic retinopathy (DR) is one of the leading causes of permanent central blindness worldwide. Despite the complexity and inadequate understanding...

    Muhammad Zulfiqah Sadikan, Nurul Alimah Abdul Nasir in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 04 July 2023
  10. Macrophage activation contributes to diabetic retinopathy

    Diabetic retinopathy (DR) is recognized as a neurovascular complication of diabetes, and emerging evidence underscores the pivotal role of...

    Yi Zhang, Aiyi Zhou in Journal of Molecular Medicine
    Article 02 March 2024
  11. Exploring various novel diagnostic and therapeutic approaches in treating diabetic retinopathy

    Diabetic retinopathy is regarded as a common manifestation of diabetes mellitus, being a prominent cause of visual impairment and blindness. This...

    Ankita Sood, Suman Baishnab, ... Thakur Gurjeet Singh in Inflammopharmacology
    Article 06 February 2023
  12. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation

    Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent complication of diabetes mellitus (DM), is the leading...

    Martina Kropp, Olga Golubnitschaja, ... Gabriele Thumann in EPMA Journal
    Article Open access 13 February 2023
  13. DEC-DRR: deep ensemble of classification model for diabetic retinopathy recognition

    Abstract

    Most diabetes patients are liable to have diabetic retinopathy (DR); however, the majority of them might not be even aware of the ailment....

    L.B. Lisha, C. Helen Sulochana in Medical & Biological Engineering & Computing
    Article 07 May 2024
  14. A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25

    Diabetic retinopathy (DR) is a diabetes-associated complication that poses a threat to vision, distinguished by persistent and mild inflammation of...

    Qiang Hu, Xue Zhang, ... Dawei Sun in Inflammation
    Article Open access 04 March 2024
  15. Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study

    Background

    Diabetic retinopathy (DR) is the foremost cause of vision loss among the global working-age population, and statins are among the most...

    Chengming Chen, Huan Zhang, ... **g Han in Journal of Translational Medicine
    Article Open access 22 March 2024
  16. Serum Vitamin D As a Biomarker in Diabetic: Applications and Associations with Retinopathy

    Vitamin D is a multifunctional hormone with multiple biological functions including regulation of endothelial function, angiogenesis, antioxidant and...
    Carolina Madeira, Manuel FalcĂŁo in Biomarkers in Diabetes
    Reference work entry 2023
  17. A deep learning system for predicting time to progression of diabetic retinopathy

    Diabetic retinopathy (DR) is the leading cause of preventable blindness worldwide. The risk of DR progression is highly variable among different...

    Ling Dai, Bin Sheng, ... Wei** Jia in Nature Medicine
    Article Open access 04 January 2024
  18. A Guide to Genome-Wide Association Study Design for Diabetic Retinopathy

    Diabetic retinopathy (DR) is the most common microvascular complication related to diabetes. There is evidence that genetics play an important role...
    Rajya L. Gurung, Kathryn P. Burdon, Bennet J. McComish in Diabetic Retinopathy
    Protocol 2023
  19. Recognition of diabetic retinopathy and macular edema using deep learning

    Diabetic retinopathy (DR) and diabetic macular edema (DME) are both serious eye conditions associated with diabetes and if left untreated, and they...

    Fathe Jeribi, Tahira Nazir, ... Ali Tahir in Medical & Biological Engineering & Computing
    Article 30 April 2024
  20. Uncovering the Therapeutic Potential of Phosphocreatine in Diabetic Retinopathy: Mitigating Mitochondrial Dysfunction and Apoptosis via JAK2/STAT3 Signaling Pathway

    Diabetic retinopathy (DR) stands as a prevalent complication of diabetes mellitus, causing damage to the delicate retinal capillaries and potentially...

    Eskandar Qaed, Eman Alyafeai, ... Jianbin Zhang in Journal of Molecular Neuroscience
    Article 17 January 2024
Did you find what you were looking for? Share feedback.